Arcturus Therapeutics Holdings Inc. ARCT
8.54 USD +0.57 (+7.15%)
As ofNov 18, 2026, 10:07 AM EST
7.95 Day range 8.59
5.50 52-week range 17.96
- YTD
- +39.31%
- 1 year
- +29.00%
News
businesswire.com Arcturus Therapeutics Announces $50 Million Investment by Meiji Seika Pharma as Part of Expanded Collaboration SAN DIEGO--(BUSINESS WIRE)---- $ARCT #65Roses--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and…
benzinga.com Arcturus Therapeutics Q3 2026 Earnings Call Transcript Arcturus Therapeutics (NASDAQ:ARCT) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…benzinga.com Arcturus Therapeutics Q3 EPS $(0.26) Beats $(0.68) Estimate, Sales $18.297M Beat $7.998M Estimate Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.68) by 61.76 percent. This is a 46.94 percent increase over losses…
